The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.
Pharmaceutical firm Merck & Co’s Merck Global Health Innovation Fund has added $5m to a series D round for US-based precision medicine provider GNS Healthcare that now totals $28m.
Founded in 2000, GNS has developed artificial intelligence software that processes a range of data, enabling users to build causal models in order to predict how patients will respond to different medical treatments.
The $23m first close was led by care provider Cigna’s corporate venturing unit, Cigna Ventures, in July…
